CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net income before allocations to noncontrolling interests	$ 401.1	$ 435.4	$ 181.1
Non-cash loss on divestiture of asbestos-related assets and liabilities	148.9	0.0	0.0
Gain on sale of business	(232.5)	0.0	0.0
Gain on sale of property	(2.8)	(18.5)	0.0
Depreciation and amortization	118.9	121.1	127.5
Stock-based compensation expense	24.2	24.9	22.3
Defined benefit plans and postretirement credit	(1.3)	(8.0)	(7.1)
Deferred income taxes	(17.6)	(9.5)	18.1
Cash (used for) provided by operating working capital	2.2	(38.0)	(39.1)
Defined benefit plans and postretirement contributions	(21.8)	(29.4)	(28.4)
Environmental payments, net of reimbursements	(5.8)	(5.8)	(4.2)
Asbestos related payments, net of insurance recoveries	(29.3)	(44.9)	(31.1)
Divestiture of asbestos-related assets and liabilities	(550.0)	0.0	0.0
Other	18.6	(4.7)	(7.8)
Total (used for) provided by operating activities	(151.6)	498.5	309.5
Investing activities:
Proceeds from disposition of capital assets	4.3	23.6	4.5
Capital expenditures	(58.4)	(53.9)	(34.1)
Proceeds from sale of business	318.1	0.0	0.0
Purchase of marketable securities	0.0	(10.0)	(90.0)
Proceeds from sale of marketable securities	0.0	40.0	60.0
Payment for acquisition - net of cash acquired	0.0	0.0	(169.5)
Total provided by (used for) investing activities	264.0	(0.3)	(229.1)
Financing activities:
Dividends paid	(105.9)	(100.6)	(100.4)
Reacquisition of shares on open market	(203.7)	(96.3)	(70.0)
Stock options exercised, net of shares reacquired	16.2	14.2	5.1
Debt issuance costs	0.0	0.0	(1.3)
Proceeds from issuance of commercial paper with maturities greater than 90 days	0.0	0.0	251.3
Repayments of commercial paper with maturities greater than 90 days	0.0	(27.1)	(296.7)
Net repayments from issuance of commercial paper with maturities of 90 days or less	0.0	0.0	(76.8)
Proceeds from revolving credit facility	0.0	0.0	77.2
Repayments of revolving credit facility	0.0	0.0	(77.2)
Proceeds from term loan	399.4	0.0	343.9
Repayment of term loan	0.0	(348.1)	0.0
Total provided by (used for) financing activities	106.0	(557.9)	55.1
Effect of exchange rates on cash and cash equivalents	(39.4)	(12.7)	21.6
Increase (decrease) in cash and cash equivalents	179.0	(72.4)	157.1
Cash and cash equivalents at beginning of period	478.6	551.0	393.9
Cash and cash equivalents at end of period	657.6	478.6	551.0
Detail of cash (used for) provided by operating working capital
Accounts receivable	(46.8)	(58.8)	138.5
Inventories	(54.7)	(18.2)	35.4
Other current assets	(8.0)	(18.4)	(5.8)
Accounts payable	53.3	59.3	(102.6)
Accrued liabilities	28.8	53.8	4.8
U.S. and foreign taxes on income	25.2	20.3	(31.2)
Total	2.2	(38.0)	(39.1)
Supplemental disclosure of cash flow information:
Interest paid	47.6	44.4	53.8
Income taxes paid	$ 147.2	56.3	$ 46.5
After Adjustment
Operating activities:
Deferred income taxes		$ (9.6)